Insilico credited its AI with discovering a drug, then listed five humans on the patent.

MIT Technology Review dug into the gap between the press release saying its generative platform "discovered" a pulmonary fibrosis molecule and the patent filing naming five human inventors including CEO Alex Zhavoronkov, with no mention of the AI. MIT Technology Review US law only allows human inventors, so companies choose between marketing the AI's role and filing a patent that survives challenge. Listing the wrong inventors is itself grounds for a challenge, which turns the marketing language into a legal liability. Expect this to hit every AI-for-science claim eventually.